Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Emily L. Howard"'
Publikováno v:
Proceedings of the Human Factors and Ergonomics Society Annual Meeting. 66:383-387
Publikováno v:
Pain medicine (Malden, Mass.).
Objective Pathology can provide crucial insights into the etiology of disease. The goal of this review is to evaluate the rigor of histopathology reports of Complex Regional Pain Syndrome (CRPS). Methods A systematic search of multiple databases iden
Publikováno v:
Molecular and Cellular Biology. 19:1990-1999
The Mos protein kinase is a key regulator of vertebrate oocyte maturation. Oocyte-specific Mos protein expression is subject to translational control. In the frog Xenopus, the translation of Mos protein requires the progesterone-induced polyadenylati
Autor:
R. Neal Smith, Emily L. Howard, Kenneth R. Knecht, Robert D.B. Jaquiss, E. Steve Woodle, Terry Harville, Robert L. Saylors, Sherry Pye, Xiomara Garcia, Elizabeth A. Frazier, William T. Mahle, William R. Morrow
Publikováno v:
Transplantation. 93(3)
Anti-human leukocyte antigen (HLA) sensitization of potential heart transplant recipients is encountered frequently due to previous cardiac surgery or mechanically assisted device placement, and presence of anti-HLA antibodies is associated with decr
Autor:
Christopher, Roser-Jones, Mark, Chan, Emily L, Howard, Kristian C D, Becker, Christopher P, Rusconi, Richard C, Becker
Publikováno v:
Cardiovascular therapeutics. 29(4)
Anticoagulant therapy, combined with platelet-directed inhibitors, represents a standard-of-care in the management of patients with acute coronary syndrome, particularly those who require percutaneous coronary interventions. While a vast clinical exp
Publikováno v:
Fundamental and Clinical Cardiology Series ISBN: 1420069241
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67e3b59141cb9d095283ccfadeb21d9b
https://doi.org/10.3109/9781420069242.021
https://doi.org/10.3109/9781420069242.021
Publikováno v:
Arteriosclerosis, thrombosis, and vascular biology. 27(4)
Currently available anticoagulants are limited by modest therapeutic benefits, narrow clinical applications, increased bleeding risk, and drug-induced thrombophilia. Because factor IX plays a pivotal role in tissue factor (TF)–mediated thrombin gen